Elevation Oncology (ELEV) Competitors $0.36 0.00 (0.00%) As of 07/23/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELEV vs. XBIT, CABA, WHWK, ANRO, JMAC, EXOZ, EPIX, MIST, QNCX, and ELUTShould you be buying Elevation Oncology stock or one of its competitors? The main competitors of Elevation Oncology include XBiotech (XBIT), Cabaletta Bio (CABA), Whitehawk Therapeutics (WHWK), Alto Neuroscience (ANRO), Maxpro Capital Acquisition (JMAC), eXoZymes (EXOZ), ESSA Pharma (EPIX), Milestone Pharmaceuticals (MIST), Quince Therapeutics (QNCX), and Elutia (ELUT). These companies are all part of the "pharmaceutical products" industry. Elevation Oncology vs. Its Competitors XBiotech Cabaletta Bio Whitehawk Therapeutics Alto Neuroscience Maxpro Capital Acquisition eXoZymes ESSA Pharma Milestone Pharmaceuticals Quince Therapeutics Elutia XBiotech (NASDAQ:XBIT) and Elevation Oncology (NASDAQ:ELEV) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Does the media favor XBIT or ELEV? In the previous week, XBiotech had 3 more articles in the media than Elevation Oncology. MarketBeat recorded 3 mentions for XBiotech and 0 mentions for Elevation Oncology. XBiotech's average media sentiment score of 0.57 beat Elevation Oncology's score of 0.00 indicating that XBiotech is being referred to more favorably in the media. Company Overall Sentiment XBiotech Positive Elevation Oncology Neutral Do insiders and institutionals have more ownership in XBIT or ELEV? 55.7% of XBiotech shares are held by institutional investors. Comparatively, 83.7% of Elevation Oncology shares are held by institutional investors. 30.8% of XBiotech shares are held by insiders. Comparatively, 8.1% of Elevation Oncology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, XBIT or ELEV? XBiotech has higher revenue and earnings than Elevation Oncology. XBiotech is trading at a lower price-to-earnings ratio than Elevation Oncology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXBiotech$4.01M21.67-$38.53M-$1.29-2.21Elevation OncologyN/AN/A-$44.49M-$0.82-0.45 Which has more volatility & risk, XBIT or ELEV? XBiotech has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, Elevation Oncology has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Do analysts rate XBIT or ELEV? Elevation Oncology has a consensus price target of $3.39, suggesting a potential upside of 827.59%. Given Elevation Oncology's stronger consensus rating and higher possible upside, analysts clearly believe Elevation Oncology is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Elevation Oncology 0 Sell rating(s) 11 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is XBIT or ELEV more profitable? XBiotech's return on equity of -21.14% beat Elevation Oncology's return on equity.Company Net Margins Return on Equity Return on Assets XBiotechN/A -21.14% -19.55% Elevation Oncology N/A -74.68%-48.14% SummaryXBiotech beats Elevation Oncology on 7 of the 13 factors compared between the two stocks. Get Elevation Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for ELEV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ELEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELEV vs. The Competition Export to ExcelMetricElevation OncologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.62M$3.00B$5.48B$9.51BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-0.4517.6228.6723.80Price / SalesN/A179.18373.9066.58Price / CashN/A41.9535.4557.96Price / Book0.368.508.275.55Net Income-$44.49M-$55.06M$3.24B$259.03M7 Day PerformanceN/A-3.98%-3.69%-4.59%1 Month Performance-3.62%9.59%4.33%4.46%1 Year Performance-84.60%6.72%25.95%18.03% Elevation Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELEVElevation Oncology2.6793 of 5 stars$0.37flat$3.39+827.6%N/A$21.62MN/A-0.4540Upcoming EarningsXBITXBiotech0.992 of 5 stars$2.82-1.7%N/A-61.0%$85.98MN/A-2.19100News CoveragePositive NewsShort Interest ↑CABACabaletta Bio1.8014 of 5 stars$1.69+1.8%$14.43+753.8%-79.1%$85.75MN/A-0.6750Upcoming EarningsWHWKWhitehawk TherapeuticsN/A$1.81-7.2%N/AN/A$85.27M$25.98M11.3140ANROAlto Neuroscience1.8576 of 5 stars$3.11+0.8%$8.50+173.8%-68.6%$84.06MN/A-1.33N/ANews CoverageJMACMaxpro Capital AcquisitionN/A$6.23+1.3%N/A+2,963.2%$83.66MN/A0.002,021News CoverageGap UpEXOZeXoZymesN/A$9.93-0.5%N/AN/A$83.09MN/A0.0029EPIXESSA Pharma1.1884 of 5 stars$1.87-0.5%$2.00+7.0%-63.4%$83.01MN/A-2.9750News CoverageUpcoming EarningsMISTMilestone Pharmaceuticals1.8184 of 5 stars$1.55-1.9%$7.00+351.6%+2.9%$82.86M$1M-1.9930Positive NewsUpcoming EarningsShort Interest ↑QNCXQuince Therapeutics2.4373 of 5 stars$1.80-2.7%$8.00+344.4%+125.9%$81.85MN/A-1.2960Short Interest ↑ELUTElutia3.4514 of 5 stars$1.97+2.6%$8.00+306.1%-40.4%$81.00M$23.71M-1.02180News CoverageUpcoming EarningsGap Down Related Companies and Tools Related Companies XBIT Alternatives CABA Alternatives WHWK Alternatives ANRO Alternatives JMAC Alternatives EXOZ Alternatives EPIX Alternatives MIST Alternatives QNCX Alternatives ELUT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELEV) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevation Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elevation Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELEV Stock Alerts